CWRU research yields Alzheimer’s breakthrough

Case Western Reserve University School of Medicine research, published in the journal Science, show that use of a drug currently prescribed to treat cancer appears to reverse Alzheimer’s symptoms in mice. Results point to significant potential that the medication, bexarotene, may help the roughly 5.4 million Americans with the progressive brain disease. This a great example of drug “repurposing” discussed here a couple days ago.

Crain’s Cleveland Business did a nice write-up on the researchers, Gary Landreth and Paige Cramer, and their newly formed company, ReXceptor, Inc. And this video produced by Case does an excellent job of explaining the research.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

ProMedica of Toledo OH invests in VentureMed Group, a start-up focused on revolutionizing vascular surgery | ProMedica, November 24, 2014

Surgical Theater’s technology to be showcased at the opening of the Besta NeuroSim Center in Milan, Italy | PR Newswire, November 24, 2014

Cardinal Health and Henry Schein long-term agreement to serve physician offices, Cardinal’s physician office-focused organization consolidated into Henry Schein’s Medical Group | Cardinal Health, November 21, 2014

Cincinnati Children’s Hospital Medical Center researchers figured out how to reduce heart monitor false alarms by nearly 80 percent | Cincinnati Business Courier, November 21, 2014

Summa Helath one of four US hospitals offering new cancer treatment option, the Vero stereotactic body radiotherapy (SBRT) system | Akron Beacon Journal, November 21, 2014

Cardinal Health, Henry Schein join to get medical supplies in doctor offices | Columbus Business First, November 21, 2014

Florida Blue and Miami Children’s Hospital to offer HealthSpot’s telehealth kiosks in Miami | PR Newswire, November 21, 2014

Navidea’s Lymphoseek approved for sale in Europe | Columbus Business First, November 20, 2014

Codonics honored by Frost & Sullivan for enhancing patient safety and accuracy of medication management with the Safe Label System | Frost & Sullivan, November 20, 2014

Microbial Robotics’ new genetics rights management product platform enters international markets with patent filing | PR Newswire, November 19, 2014

Matrix Medical Devices of Cleveland purchases Mentor-based REU Associates | Crains Cleveland Business, November 19, 2014

Global Emerging Pathogen Treatment Consortium formed to study potential of immune plasma treatment in the fight against Ebola, ClinicalRM, USAMRIID | PR Newswire, November 19, 2014

Freedom Meditech granted key U.S. patent covering the ClearPath DS-120 device and method of use | PR Newswire, November 19, 2014

New Ricerca CEO remains positive as questions linger over company | Outsourcing Pharma, November 19, 2014

Duet Health robot finding applications beyond patient education | Columbus Business First, November 19, 2014

Cleveland Clinic and Parker Hannifin developing hundreds of potential medical advancments | MedCity News, November 18, 2014

Ohio State University Comprehensive Cancer Center researcher wins supercomputing award for cancer research | Ohio Supercomputer Center, November 18, 2014

CTI Clinical Trial and Consulting Services opens office in Belgium, their sixth new location this year | Cincinnati Business Courier, November 18, 2014

Successful “Date Certain M&A” of AxioMed Spine Corp. its assets and intellectual property | Gerbsman Partners, November 18, 2014

889 Global Solutions profiled by WOSU Career Connections Series (video) | WOSU Public Media via YouTube, November 18, 2014